![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07C 237/22 | |
A61K 31/166 | |||
A61P 29/00 |
(11) | Patento numeris | 2870137 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13737357.7 |
Europos patento paraiškos padavimo data | 2013-07-05 | |
(97) | Europos patento paraiškos paskelbimo data | 2015-05-13 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-16 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/GB2013/051781 |
Data | 2013-07-05 |
(87) | Numeris | WO 2014/006414 |
Data | 2014-01-09 |
(30) | Numeris | Data | Šalis |
201261668543 P | 2012-07-06 | US | |
201212081 | 2012-07-06 | GB |
(72) |
NORTHEN, Julian Scott, GB
MYKYTIUK, John, GB
|
(73) |
Kalvista Pharmaceuticals Limited,
Porton Science Park Incubator Centre Bybrook Road, Porton Down Wiltshire SP4 0BF,
GB
|
(54) | POLYMORPHS OF N-[(R)-1-[(S)-1-(4-AMINOMETHYL-BENZYLCARBAMOYL)-2-PHENYL-ETHYLCARBAMOYL]-2-(4-ETHOXY-PHENYL)-ETHYL]-BENZAMIDE HYDROCHLORIDE |
POLYMORPHS OF N-[(R)-1-[(S)-1-(4-AMINOMETHYL-BENZYLCARBAMOYL)-2-PHENYL-ETHYLCARBAMOYL]-2-(4-ETHOXY-PHENYL)-ETHYL]-BENZAMIDE HYDROCHLORIDE |